What 3CK does

3CK S.r.l. is an Italian medical device company headquartered in Arzignano, Vicenza, that designs and manufactures single-use prefilled syringes for pharmaceutical manufacturers, healthcare providers, and patient self-injection applications. The company markets two product lines: C-PAD, a 5th-generation prefilled syringe built on a SYFPAC Blow Fill Seal (BFS) machine targeting mass vaccination campaigns and self-injectable contraceptives at volumes of 0.5-2.5 mL and output rates of up to 20,000 units/hour; and O-FLOW, a next-generation prefilled and prefillable syringe spanning 0.5-20 mL that eliminates break-loose force and removes the need for silicone oil lubrication while retaining standard Luer-slip/Luer-lock compatibility. Both products share an autodisabling, single-use non-return valve mechanism and are produced via closed-parison BFS, in which syringes are created, aseptically filled, and sealed in one continuous automated operation.

The underlying technology is mechanical and aseptic-processing rather than digital: a proprietary BFS closed-parison process, an integrated non-return/autodisabling valve, a silicone-oil-free plunger membrane (O-FLOW), and a large printable syringe ring that prevents marking ink from contacting the drug product. The company sells directly via its website (3ckmed.com), using "Request Info" and "Request Samples" forms as primary lead-conversion touchpoints, and supplements this with industry-event activity, most notably CPHI Worldwide 2025 in Germany (28-30 October 2025).

3CK is structured as an Italian S.r.l. (limited liability company) with declared share capital of €50,000, employs 1-10 people, has not disclosed any external funding rounds, customers, partnerships, or revenue figures, and generates (or intends to generate) revenue from hardware sales of C-PAD and O-FLOW devices — primarily through direct engagement with pharmaceutical manufacturers and healthcare institutions. Pricing is not publicly disclosed, and all commercial qualification is routed through the website contact channel rather than through resellers or integrators.

Name

3CK

Legal name

3CK S.r.l.

Website

https://3ckmed.com

Company type

Private

Operating status

Operating

Headcount range

1–10 employees

Short description

3CK S.r.l. is an Italian medical device company that designs and manufactures single-use prefilled syringes (C-PAD and O-FLOW) using Blow Fill Seal technology, serving pharmaceutical manufacturers, vaccination programs, healthcare providers, and patients requiring self-injectable drug delivery.

Ownership category

akta.pro rank

Product category

Prefilled Syringes

NAICS

Surgical and Medical Instrument Manufacturing (339112), Surgical Appliance and Supplies Manufacturing (339113)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Prefilled Syringes & Safety Syringes (HLAHAIAA)

akta.pro secondary industries

Parenteral & Injectable Packaging Components (Stoppers, Seals, Syringes, Cartridges) (IMALAIAE), Sterile & Aseptic Medical Packaging (Pouches, Wraps, Sterile Barriers) (IMALAIAB)

Keywords

• Prefilled syringes
• Blow fill seal
• Medical devices
• Pharmaceutical packaging
• Single-use syringes

Headquarters

HQ city

Arzignano

HQ country

Italy

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Technology or R&D, Personnel, Marketing or Sales

Revenue model

1. Medical Device Sales: 3CK generates revenue through the sale of prefilled syringes (C-PAD and O-FLOW) to pharmaceutical manufacturers, healthcare providers, and vaccination programs. The company sells both finished devices and possibly bulk manufacturing capacity.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

3CK designs, develops and manufactures single-use prefilled syringes using Blow Fill Seal (BFS) technology, sold under two product lines — C-PAD (0.5–2.5 mL, autodisabling, for mass vaccination and self-injection) and O-FLOW (0.5–20 mL, silicone-oil-free with zero break-loose force). The devices are offered to pharmaceutical manufacturers, vaccine producers and healthcare providers for drug delivery and vaccination campaigns, with production throughput up to 20,000 units per hour.

Product overview

3CK offers a portfolio of two prefilled syringe product lines: C-PAD and O-FLOW. C-PAD is a 5th-generation prefilled syringe utilizing Blow Fill Seal technology, designed for autodisabling single-use applications with volumes of 0.5 to 2.5 mL. O-FLOW represents an advanced next-generation line featuring silicone oil-free construction, no break-loose force, and broader volume scalability from 0.5 to 20 mL. Both products share autodisabling safety mechanisms and standard Luer ports, serving mass vaccination campaigns, healthcare professionals, and patients requiring self-injection capabilities.

Differentiator

Problem solved

Functional benefit

Brands

• C-PAD: The prefilled syringe made on Blow Fill Seal technology. Equipped with a non-return valve which makes it autodisabling, ensuring single use and preventing contamination. Suitable for vaccination campaigns and self-injection of contraceptives. Volumes scalable from 0.5 to 2.5 ml.
• O-FLOW

Products and services

• C-PAD A prefilled syringe manufactured using Blow Fill Seal technology, featuring an autodisabling non-return valve that ensures single-use and prevents contamination. Designed for mass vaccination campaigns and self-injection of contraceptives, with scalable volumes from 0.5 to 2.5 mL and production rates of up to 20,000 units per hour. Targeted at pharmaceutical manufacturers and healthcare providers.
• O-FLOW A next-generation prefilled and prefillable syringe featuring a design that eliminates break-loose force and requires no silicone oil. Includes an autodisabling mechanism, standard Luer-slip or Luer-lock ports, a large safe printing area, and scalable fillable volumes from 0.5 mL to 20 mL, supporting production from thousands to hundreds of millions of units. Targeted at pharmaceutical manufacturers and healthcare providers.

Quantifiable outcome

• Up to 20,000 units produced per hour on C-PAD BFS production line
• +1 more outcomes

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Scale indicators3 records

Recent moves4 records

Expansion highlights4 records

Direct peers

• Nipro: Japanese medical device and pharmaceutical glass company with a dedicated prefilled syringe business; competes with 3CK on prefilled and prefillable syringe offerings for injectables.
• Stevanato Group: Italian-headquartered provider of drug containment and delivery solutions including prefilled syringes and BFS-based platforms; directly comparable in geography, technology, and customer base to 3CK.
• Gerresheimer: Global manufacturer of pharmaceutical packaging and drug delivery devices, including prefilled glass and polymer syringes serving the same pharmaceutical and vaccination customers as 3CK.

Others

• Catalent: Global CDMO providing fill-finish and drug delivery services for injectables; relevant as a potential partner or customer for 3CK's BFS syringe technology rather than a direct device competitor.

Broad incumbents

• Schott: Manufacturer of pharmaceutical glass and specialty packaging including syringes and cartridges; overlaps with 3CK on parenteral drug delivery packaging solutions.
• Becton, Dickinson and Company (BD): One of the largest players in prefilled syringes (BD Hypak, BD UltraSafe) and drug delivery systems; competes with 3CK across vaccine, biologic, and self-injection use cases.
• Aptar Pharma: Division of AptarGroup supplying elastomeric and plastic components, prefilled system components, and drug delivery devices for injectables and nasal/pulmonary routes.
• West Pharmaceutical Services: Global supplier of elastomer components, stoppers, seals, and integrated delivery systems for injectable drugs, addressing the same pharma containment and delivery market as 3CK.
• AptarGroup (Drug Delivery): Parent of Aptar Pharma with broader drug delivery portfolio including injectables; competes in the same customer RFPs as 3CK for prefilled and self-injection devices.

Regional players

• Bormioli Pharma: Italian pharmaceutical packaging manufacturer of vials, syringes, and containers; shares 3CK's Italian manufacturing base and serves overlapping European pharma customers.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/3ck-srl

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about 3CK